Artificial intelligence is no longer a distant prospect in medicine—it is reshaping patient care, biomedical discovery, and healthcare efficiency. Leading medical institutions must prepare future leaders to harness AI in tackling the most…
Jack Hidary, SandboxAQ, and Jim Breyer, Breyer Capital founder and CEO, join ‘Money Movers’ to discuss what Sandbox is and the technological edge the company has, why Breyer is so excited about the large quantitative model, and how to…
Breyer Capital founder and CEO Jim Breyer speaks with Lisa Abramowicz at the World Economic Forum’s annual meeting in Davos, Switzerland. (Source: Bloomberg)
Called Arena BioWorks, the new organization has been in the works for several years. For Schreiber, the seeds were planted in early 2020. He and Thomas Cahill, cofounder and managing director of the investment firm Newpath Partners, had…
Since our last Healthcare AI investment thesis update, we’ve experienced a continuing and profound transformation at the intersection of healthcare, life sciences, and artificial intelligence (AI). At Breyer Capital, we’ve been investing…
Jim Breyer, Breyer Capital founder and CEO, joins ‘Squawk on the Street’ to discuss Breyer’s call on Nvidia back at Davos, Alphabet’s proprietary chip sets and the chief executive’s thoughts on Meta.
Uncertain markets have investors backing away from risky bets on unproven technology and promises of world-changing innovation. Then there’s quantum computing—a field that seeks to harness quantum physics to power supercomputers with…
While McIlroy and Spieth are two of golf’s most accomplished and well-known current pros, GOLF+’s newest investment group – led by Breyer Capital – also extends to 70-year-old Ben Crenshaw, a two-time Masters winner and one of golf’s most…